Adnavance Technologies
San Diego
About Adnavance Technologies
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNA™) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $7.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2008)
- Website: adnavance.com
- Phone: +1 858-523-9250
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/adnavance-technologies-3597393 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.